Clinical Trials

NCT04979806 | COMPLETED | PHASE3

530 participants

Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2022-08-28

Completion:

2024-11-25

Conditions

• Complicated Urinary Tract Infection
• Acute Pyelonephritis

Interventions

• DRUG

Results Available

NCT04975217 | SUSPENDED | EARLY_PHASE1

10 participants

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-12-14

Completion:

2026-12-31

Conditions

• Pancreatic Ductal Adenocarcinoma

Interventions

• PROCEDURE
• DRUG
• OTHER

No Results Yet

NCT04961996 | ACTIVE_NOT_RECRUITING | PHASE3

4170 participants

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-08-27

Completion:

2025-08-08

Conditions

• Early Breast Cancer

Interventions

• DRUG

No Results Yet

NCT04958252 | COMPLETED | PHASE1

56 participants

A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-08-05

Completion:

2023-10-30

Conditions

• Healthy

Interventions

• DRUG

Results Available

NCT04957719 | ENROLLING_BY_INVITATION | PHASE3

25000 participants

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-08-14

Completion:

2026-12-31

Conditions

• Acute Myocardial Infarction

Interventions

• COMBINATION_PRODUCT

No Results Yet

NCT04957355 | RECRUITING | NA

20 participants

Effect of NMES on Balance and Fall Risk in Chronic Stroke

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-05-15

Completion:

2027-08-31

Conditions

• Chronic Stroke

Interventions

• DEVICE

No Results Yet

NCT04953806 | ACTIVE_NOT_RECRUITING | NA

45 participants

The Development of an Integrated Physical Activity and Mental Health Intervention for Veterans With COPD, Emotion Distress, and Low Physical Activity

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-11-02

Completion:

2026-10-31

Conditions

• COPD
• Depression
• Anxiety

Interventions

• BEHAVIORAL

No Results Yet

NCT04946851 | ENROLLING_BY_INVITATION

1400 participants

Addictions Neuroclinical Assessment (ANA)

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2021-08-12

Completion:

2031-12-31

Conditions

• Normal Physiology
• Alcohol Use Disorder

No Results Yet

NCT04940052 | ACTIVE_NOT_RECRUITING | PHASE3

153 participants

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-11-15

Completion:

2025-01-22

Conditions

• Differentiated Thyroid Cancer (DTC)

Interventions

• DRUG

Results Available

NCT04939350 | COMPLETED

742 participants

Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2021-09-27

Completion:

2022-12-27

Conditions

• Cirrhosis

Interventions

• OTHER

No Results Yet

NCT04933539 | ACTIVE_NOT_RECRUITING | PHASE2

14 participants

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2022-10-31

Completion:

2026-08-31

Conditions

• Multiple Myeloma

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT04929288 | RECRUITING | NA

100 participants

Neural and Hormonal Influences on Sex Differences in Risk for AUD

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-05-11

Completion:

2027-06-30

Conditions

• Alcohol Use Disorder

Interventions

• DRUG

No Results Yet

NCT04927416 | RECRUITING | PHASE2

54 participants

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-10-25

Completion:

2030-11-30

Conditions

• Metastic Thyroid Cancer

Interventions

• DRUG

No Results Yet

NCT04926922 | COMPLETED

200 participants

PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2021-07-27

Completion:

2026-04-30

Conditions

• Tuberculosis
• HIV

No Results Yet

NCT04921514 | COMPLETED | NA

45 participants

Psychological Sequelae After Sudden Cardiac Death in the Patient and His Relatives

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-05-18

Completion:

2022-09-26

Conditions

• Post Traumatic Stress Disorder
• Resuscitated Sudden Cardiac Death

Interventions

• BEHAVIORAL

No Results Yet

NCT04915183 | RECRUITING | PHASE2

224 participants

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-07-10

Completion:

2028-08-01

Conditions

• Hearing Loss
• Head and Neck Cancer

Interventions

• OTHER
• DRUG

No Results Yet

NCT04910841 | RECRUITING | NA

55 participants

Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medicine

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-09-11

Completion:

2026-09-30

Conditions

• Hyperglycemia
• Hypotension
• Shock, Septic

Interventions

• DEVICE

No Results Yet

NCT04910685 | RECRUITING | PHASE2/PHASE3

534 participants

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-11-30

Completion:

2032-09-30

Conditions

• Indolent Systemic Mastocytosis
• Smoldering Systemic Mastocytosis

Interventions

• DRUG

No Results Yet

NCT04905693 | ENROLLING_BY_INVITATION | PHASE3

1850 participants

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2022-09-06

Completion:

2026-06-30

Conditions

• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease
• Progressive Pulmonary Fibrosis

Interventions

• DRUG
• DEVICE

No Results Yet

NCT04901195 | ACTIVE_NOT_RECRUITING | PHASE3

658 participants

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-05-27

Completion:

2026-07-28

Conditions

• Hidradenitis Suppurativa

Interventions

• DRUG

No Results Yet

NCT04889326 | WITHDRAWN

0 participants

Collection of the Thrombo-VaxCov Cohort

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2021-04-02

Completion:

2023-05-01

Conditions

• Covid19
• SARS-CoV Infection
• Venous Thrombosis
• Thrombocytopenia
• Vaccination; Complications

Interventions

• OTHER

No Results Yet

NCT04887428 | COMPLETED

343 participants

Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD)

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2019-11-28

Completion:

2023-01-28

Conditions

• Crohn Disease
• Ulcerative Colitis

No Results Yet

NCT04885504 | ACTIVE_NOT_RECRUITING

100 participants

Post COVID-19 Biorepository

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2021-02-08

Completion:

2026-12-31

Conditions

• Coronavirus Infection

No Results Yet

NCT04881799 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1

13 participants

Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2022-07-07

Completion:

2025-10-27

Conditions

• Pediatric Obesity

Interventions

• DRUG

Results Available

NCT04877691 | ACTIVE_NOT_RECRUITING | PHASE3

367 participants

Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-06-08

Completion:

2025-08-22

Conditions

• Systemic Lupus Erythematosus

Interventions

• DRUG

No Results Yet

NCT04869670 | TERMINATED | NA

3 participants

A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-07-12

Completion:

2025-03-03

Conditions

• Gastroparesis

Interventions

• PROCEDURE

Results Available

NCT04864886 | RECRUITING

300 participants

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2021-08-10

Completion:

2027-06-30

Conditions

• Primary Immunodeficiency
• Psoriasis
• Atopic Dermatitis
• Immune-mediated Diseases

No Results Yet

NCT04858269 | ACTIVE_NOT_RECRUITING | PHASE2

32 participants

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-05-27

Completion:

2026-06-30

Conditions

• Head Neck Cancer
• Metastatic Squamous Cell Carcinoma
• Oral Cavity Squamous Cell Carcinoma
• Oropharynx Squamous Cell Carcinoma
• Hypopharynx Squamous Cell Carcinoma
• Larynx Squamous Cell Carcinoma

Interventions

• DRUG

No Results Yet

NCT04846920 | COMPLETED | PHASE1

29 participants

A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-06-14

Completion:

2026-04-11

Conditions

• Carcinoma, Renal Cell

Interventions

• DRUG

No Results Yet

NCT04841811 | ACTIVE_NOT_RECRUITING | PHASE3

192 participants

MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2022-06-20

Completion:

2026-12-31

Conditions

• Lung Cancer

Interventions

• DRUG

No Results Yet

NCT04830709 | RECRUITING

750 participants

Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2021-06-15

Completion:

2033-03-31

Conditions

• Ovarian Cancer

No Results Yet

NCT04826341 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

35 participants

A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-09-20

Completion:

2028-03-01

Conditions

• HRD Cancer
• SCLC
• Advanced Solid Tumors

Interventions

• DRUG

No Results Yet

NCT04821089 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

727 participants

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-04-06

Completion:

2026-08-31

Conditions

• Moderate to Severe Upper Facial Lines

Interventions

• BIOLOGICAL

No Results Yet

NCT04813627 | COMPLETED

2079 participants

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2021-07-02

Completion:

2025-04-23

Conditions

• Colorectal Cancer Stage II
• Colorectal Cancer Stage III

Interventions

• PROCEDURE

No Results Yet

NCT04811703 | RECRUITING | PHASE1

15 participants

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-07-30

Completion:

2028-06-30

Conditions

• Metastatic Ovarian Carcinoma
• Peritoneal Carcinomatosis
• Stage III Ovarian Cancer
• Stage IV Ovarian Cancer
• Stage III Fallopian Tube Cancer
• Stage IV Fallopian Tube Cancer
• Metastatic Malignant Neoplasm in the Peritoneum

Interventions

• DRUG

No Results Yet

NCT04807270 | COMPLETED | NA

96 participants

PRP Effectiveness in Knee Osteoarthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-05-20

Completion:

2022-11-20

Conditions

• Knee Osteoarthritis

Interventions

• OTHER

No Results Yet

NCT04799301 | RECRUITING | PHASE1

60 participants

Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2022-02-23

Completion:

2028-01-01

Conditions

• Diet Therapy
• Healthy Volunteers

Interventions

• BEHAVIORAL

No Results Yet

NCT04792801 | ACTIVE_NOT_RECRUITING

108 participants

PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2021-06-22

Completion:

2028-06-05

Conditions

• Hepatocellular Carcinoma
• Liver Transplant

Interventions

• RADIATION

No Results Yet

NCT04786223 | ENROLLING_BY_INVITATION | PHASE2

125 participants

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-03-30

Completion:

2029-03-31

Conditions

• Lewy Body Dementia (LBD)
• Alzheimer Dementia (AD)

Interventions

• DRUG
• DIAGNOSTIC_TEST

No Results Yet

NCT04784715 | ACTIVE_NOT_RECRUITING | PHASE3

1157 participants

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2021-04-26

Completion:

2026-07-06

Conditions

• Breast Cancer; HER2-positive; Metastatic

Interventions

• DRUG

No Results Yet